Cargando…
Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells
[Image: see text] Liver fibrosis progression in chronic liver disease leads to cirrhosis, liver failure, or hepatocellular carcinoma and often ends in liver transplantation. Even with an increased understanding of liver fibrogenesis and many attempts to generate therapeutics specifically targeting f...
Autores principales: | Yu, Shan, Ericson, Matthew, Fanjul, Andrea, Erion, Derek M., Paraskevopoulou, Maria, Smith, Erin N., Cole, Banumathi, Feaver, Ryan, Holub, Corine, Gavva, Narender, Horman, Shane R., Huang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016707/ https://www.ncbi.nlm.nih.gov/pubmed/35274923 http://dx.doi.org/10.1021/acschembio.2c00006 |
Ejemplares similares
-
MiR-34a promotes fibrosis of hepatic stellate cells via the TGF-β pathway
por: Zhang, Jie, et al.
Publicado: (2021) -
Fibronectin Protects from Excessive Liver Fibrosis by Modulating the Availability of and Responsiveness of Stellate Cells to Active TGF-β
por: Kawelke, Nina, et al.
Publicado: (2011) -
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets
por: Gressner, A M, et al.
Publicado: (2006) -
Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling
por: Li, Jun, et al.
Publicado: (2019) -
Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway
por: Zhou, Ling, et al.
Publicado: (2017)